Select Earlier Investments
The general partners, prior to SVP III, are proud to have invested in the following select companies:
The ARYx mission is to make proven therapies safer. By applying its retrometabolic approach to pharmaceutical discovery and development, ARYx serves patients by fundamentally improving the safety of oral therapies in large, chronic markets while maintaining their efficacy. To optimize shareholder value, ARYx’s strategy was to become a profitable company with a continuing pipeline of products, balancing risk against rewards through collaborations with pharmaceutical partners. In November 2007 the company completed an initial public offering led by Morgan Stanley and trades under the NASDAQ symbol ARYX.
Lifeline Technologies is a health sciences development company focused on novel strategies for lowering human cholesterol absorption by using plant sterols and stanols to block the absorption of free cholesterol in the small intestine. The company is using licensed patented intellectual property from Washington University, St. Louis, to develop complementary approaches in the following three areas: dietary supplements, food ingredients and pharmaceuticals. The company has ready access to an enabling clinical technology for the measurement of human cholesterol absorption that permits rapid assessment of promising cholesterol lowering candidates and dosing regimens. Lifeline has entered into a licensing arrangement with Archer Daniels Midland Company for worldwide food and beverage applications.
Imagelock image protection and management service provided customers with instant access to information about the use and misuse of their digital image assets on the Web. Powered by BitShark patent-pending spidering and crawling technology, ImageLock.com located and digitally fingerprinted images, text, audio, MP3, and video on over nine million Web sites. At the time, over 200 million digital objects were being monitored. Tracking and monitoring information was archived to enable ongoing infringement resolution.
Privada Network was a network that allowed Internet users to communicate privately via an anonymous, secure identity. The sender’s real world identity and personal information were maintained a secret from everyone — including the Privada Network.
Speedchain is a provider of supply chain event management and global e-logistics solutions. Through a Web-native framework its solutions increase cross-enterprise collaboration and information sharing, ultimately resulting in faster shipment cycle times and improved customer service for its clients. Its global e-logistics solutions assist companies optimize their global supply chain operations by leveraging sophisticated rules based engines and intelligent algorithms. Speedchain Networks was acquired by Vastera in April, 2001.
Alacritech is a Silicon Valley company which pioneered the use of “intelligent” network interface cards to offload TCP/IP processing from the CPU of computer systems to dedicated hardware on the NIC: a concept now known as TOE.
Alacritech continues to license its patented accelerator technology, but is no longer manufacturing the ANX series of NFS accelerators. ANX customers will continue to receive strong support through a special team which has been put in place to assure that support contracts are fully met.
Callixa specialized in helping overcome the critical challenge of data access and integration in enterprises running multiple, disparate databases. Callixa provided the first enterprise platform capable of creating a standard access layer for writing and reading data to and from all data sources of an enterprise. Callixa’s solutions and services allowed companies to rapidly build business applications without the time and expense of developing and maintaining customized data integration access for each application.
Layer 7 Technologies
Layer 7 Technologies helped enterprises secure and govern interactions between their organizations and the services they use in the cloud; across the internet; and out to mobile devices.
Through its award-winning line of SOA Gateways, Cloud Brokers and API Proxies, Layer 7 gave enterprises the ability to control identity, data security, SLA and visibility requirements for sharing application data and functionality across organizational boundaries. In 2011, Layer 7 was named the 71st fastest-growing private or public technology company in North America on the Deloitte Fast 500 list. With more than 150 customers spanning six continents, Layer 7 supported the most demanding commercial and government organizations. Layer 7 solutions are FIPS compliant, STIG vulnerability tested and have met Common Criteria EAL4+ security assurance.
Attune Systems was a provider of enterprise-class Network File Management (NFM) solutions designed to reduce file management complexity while slashing operating costs and increasing scalability.
Health Hero Network was a leading innovator of technology solutions for remote health monitoring and management. These solutions demonstrated improved quality of care and cost savings in numerous published reports in medical literature, while winning industry awards as the best enabling technology for disease management. In December 2007, Health Hero was acquired by the Bosch Group.
PatientSafe Solutions obsesses over the experience of care to help care teams communicate and work together reliably and efficiently.
PatientSafe delivers measurable safety and quality improvements through a mobile platform that extends an organization’s EMR, clinical, and communication infrastructure and fits seamlessly into care team workflows.
PatientSafe’s context-driven PatientTouch® platform unifies communication with workflow by consolidating text, talk, alerts, EMR data, and clinical workflows all in one mobile app, on one device. For more than a decade, PatientTouch has helped clinicians both in and outside the hospital streamline care delivery, increase quality and lower costs.
Zomanex is a specialty pharmaceutical company dedicated to the development of proprietary pharmaceutical products based on its patented Orazom drug delivery platform. Orazom allows hydrophobic compounds to be efficiently absorbed in the small intestine, thereby permitting oral dosing of pharmaceutical compounds that have previously required iv or injectable administration. Orazom 3907, the Company’s lead product opportunity, is an application of Orazom to Paclitaxel, an effective and off-patent cancer chemotherapeutic agent.
Strutta’s platform allows brands, small business and non-profits to build contests, sweepstakes and other products in order to help them connect with and grow their audience across multiple social web channels. The social management dashboard allows brands to better understand how their participants are engaging with their brand and sharing their experiences.
Boreal has developed a revolutionary new approach for analysis of circulating tumor DNA in plasma enabling real-time monitoring of disease progression. Applications include therapy selection, monitoring, and early detection of disease. Boreal’s OnTarget™ technology selectively enriches the sample for targeted DNA sequences to reveal tumor mutations which help guide clinical decision making and improve clinical trials or drug development programs.
Copperleaf is a leading provider of decision analytics solutions for organizations facing the challenges of aging infrastructure. The technology leverages operational and financial data to empower these organizations to make the highest value investment decisions. Copperleaf C55 is a unique Asset Investment Planning & Management (AIPM) solution that helps customers make risk-informed decisions that are effective, transparent and focused on long-term performance.
BuildDirect is the world’s largest online marketplace for home improvement products. The Company connects homeowners directly to the suppliers of home improvement products, which eliminates heavy retail markups and makes for a much simpler and trusted shopping experience.
GenoLogics is a developer of industry leading laboratory information management systems (LIMS) for life sciences organizations. Adopted by over 120 genomic labs worldwide, GenoLogics’ Clarity LIMS™ software enables lab efficiencies and improved sample throughput with increased accuracy, fast turnaround, sample traceability, and preconfigured instrument integrations.
Bitfone offers mProve software, a software solution that helps wireless service providers do over-the-air mobile repairs and upgrades. Acquired by HP in December 2006.
Current Investments (SVP III)
CoinFlip is a conversion and payment platform technology solution that enables consumers to use their loyalty points and miles for purchases at brick-and-mortar retail locations. CoinFlip’s proprietary technology facilitates conversion of points and miles to payment transactions, simplifies the transactional accounting, and provides access to valuable data streams.
DBM Cloud Systems
DBM Cloud Systems provides software for the management of Cloud data in a hybrid and multi-Cloud environment. DBM solves three key challenges including 1) the technical challenge of efficiently moving data between Clouds to access desired services, 2) the financial problem of getting locked into a single Cloud vendor who may not provide the lowest cost services and 3) the policy compliance challenge of making sure your data resides where it should due to legal constraints or corporate policy.
Blab delivers a real time marketing platform that uses proprietary patterning technology that processes messy big data in real-time to predict target audience interest and emerging conversations, by time and channel, with a high degree of accuracy. Blab’s patterning algorithms analyze a million conversations per minute; predict how those conversations will grow in volume and velocity, and where they will migrate by channel, up to 72 hours in the future. This dynamic and real-time predictive intelligence is being used by advertising agencies, PR firms and brands, among others, to optimize media and content, as well as mitigate risk.
Microdermics is a Vancouver-based medical device company focused on commercializing a novel hollow microneedle delivery platform targeting the multi-billion biopharmaceutical market. Microdermics’ platform aims to revolutionize the traditional hypodermic needle-based drug injection by increasing efficiency, eliminating pain, and improving personnel and patient safety.
Zomanex Canada is a worldwide licensee of IP to convert certain IV-administered drugs to oral delivery. The lead candidates are oral versions of paclitaxel and docetaxel, two frontline oncology drugs used in the treatment of various cancers including ovarian, lung and breast cancer. Zomanex Canada has the exclusive worldwide license to develop and market the drugs and a first option to negotiate other molecules. The licensor, Zomanex USA, is a Shoreline II company.